Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

871
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
871
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

1.2K
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.2K
Depression: Overview01:18

Depression: Overview

1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K
Human Genetics01:28

Human Genetics

1.9K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.9K
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

134.6K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
134.6K
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

1.2K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dietary Quality in Bipolar Disorder Compared to Unipolar Depression (Current and Remitted) and Healthy Controls: The Netherlands Study of Depression and Anxiety.

Bipolar disorders·2026
Same author

Brexanolone infusion produces sustained anti-inflammatory and neurotrophic effects in patients with postpartum depression that predict symptom improvement.

Translational psychiatry·2026
Same author

Inflammation, metabolic dysregulation, and depression profiles related to anhedonia and atypical, energy-related symptoms.

Brain, behavior, and immunity·2025
Same author

Functional polygenic risk score of glucocorticoid-dependent regulatory element activity and its relation to clinical and stress-related phenotypes.

Psychoneuroendocrinology·2025
Same author

Insights from a methylome-wide association study of antidepressant exposure.

Nature communications·2025
Same author

[Discontinuation of psychotropic medication: a critical review of the evidence].

Tijdschrift voor psychiatrie·2025
Same journal

Molecular genetic influences on sustained attention and executive processes and their links with psychopathology in the AFFECT study.

Molecular psychiatry·2026
Same journal

α<sub>2</sub>-Adrenergic receptor modulates 5-HT<sub>2A</sub>-mediated behavioral effects of MDMA and psilocybin in mice.

Molecular psychiatry·2026
Same journal

Nonsense-mediated decay influences position-dependent effects of SCN2A premature stop codons on neuronal excitability and behavior.

Molecular psychiatry·2026
Same journal

Depression in neurodegenerative disease: neurobiological mechanisms and emerging treatments.

Molecular psychiatry·2026
Same journal

Cognitive and affective effects of L-Theanine: a systematic review and meta-analysis of 31 randomized trials.

Molecular psychiatry·2026
Same journal

Diagnostic and sex effects on frontostriatal brain wiring structural organization in early psychosis affective subjects compared to healthy controls.

Molecular psychiatry·2026
See all related articles

Related Experiment Video

Updated: Apr 12, 2026

Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

8.4K

Gene expression in major depressive disorder.

R Jansen1, B W J H Penninx1, V Madar2

  • 1Department of Psychiatry, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands.

Molecular Psychiatry
|May 27, 2015
PubMed
Summary
This summary is machine-generated.

This study reveals significant gene expression differences in major depressive disorder (MDD), highlighting immune pathway involvement. Current MDD state measurably impacts gene expression, particularly in interleukin-6 (IL-6) signaling and natural killer (NK) cell pathways.

More Related Videos

The Forced Swim Test as a Model of Depressive-like Behavior
05:42

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

40.6K
Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

1.7K

Related Experiment Videos

Last Updated: Apr 12, 2026

Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

8.4K
The Forced Swim Test as a Model of Depressive-like Behavior
05:42

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

40.6K
Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

1.7K

Area of Science:

  • Neuroscience
  • Genetics
  • Immunology

Background:

  • Genetic variant identification for major depressive disorder (MDD) has yielded limited insights into its molecular basis.
  • Gene expression analysis in peripheral blood offers a complementary approach to understanding MDD.
  • Previous research suggests a role for immune system dysregulation in MDD etiology.

Purpose of the Study:

  • To investigate gene expression patterns associated with major depressive disorder (MDD) in a large cohort.
  • To identify specific immune-related pathways implicated in the molecular pathology of MDD.
  • To examine the longitudinal changes in gene expression related to MDD status.

Main Methods:

  • Gene expression profiling was conducted on peripheral blood samples from 1848 subjects with current MDD, remitted MDD, and controls.
  • Longitudinal data were collected from 414 subjects after 2 years to assess changes in gene expression.
  • Statistical analyses, including false-discovery rate (FDR) control, were used to identify significant gene expression differences and pathway enrichments.

Main Results:

  • Significant differences in gene expression were observed between current MDD and control groups (129 genes at FDR<0.1).
  • Gene expression changes were largely independent of antidepressant use, inflammation, and blood cell counts.
  • Enriched pathways included interleukin-6 (IL-6) signaling (upregulated) and natural killer (NK) cell activation (downregulated) in current MDD patients.

Conclusions:

  • Current MDD state has a measurable impact on peripheral blood gene expression.
  • Identified gene expression patterns and clusters are significantly enriched in immune pathways, supporting immune involvement in MDD.
  • Findings align with both immune suppression and immune activation hypotheses of major depressive disorder.